Login

Clinical Trials for Special Populations - Dr. Robert Jacobson, a Professor of Pediatric and Adolescent Medicine 00:00:00

Share On Facebook Share On Twitter

Clinical Trials for Special Populations

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Founded by former Dreamworks CEO Jeffrey Katzenberg and former Dropbox Head of Business Sujay Jaswa|Sujay Jaswa,Founding Partner,WndrCo
00:10:00
Top Stock Picks: Steve Madden, PrivateBancorp, Hilton, and Tractor Supply
00:10:00
Journey into Investing: Understanding the Basics and Navigating the Markets | Tom O'Halloran , Portfolio Manager ,  Lord Abbett.
00:10:00
Empowering Local Talent: The ESS Manager-in-Training Program
00:10:00
NCR Atleos, now an independent company transforming the ATM industry, features CEO Tim Oliver in an interview.|Michael D. Hayford Retiring as NCR Chief Executive Officer
00:10:00
John Belizaire, CEO of Soluna Holdings, Inc., addresses shareholders' and potential investors' most frequently asked questions about the company.
00:10:00
Healthcare Investment Trends: Challenges and Opportunities Ahead
00:10:00
Biocept's Liquid Biopsy Innovations: CEO Mike Nall Discusses 2019 Achievements and 2020 Outlook
00:10:00
Venture capital firm that invests in start-ups that apply data and technology to disrupt existing industries|David Waxman,Managing Partner,TenOneTen Ventures
00:10:00
AEMX Exploration's Pom Project: Advancing High-Grade Gold Discovery with New Funding
00:10:00
Analytical tools and techniques to reverse engineer and characterise the composition of reference products|Michael Kotsanis,CEO,Acrux Ltd
00:10:00
Vimy Resources: Advancing Australia's Uranium Sector

© 2026 Nehu